Barrigel

The Future of Prostate Spacing is Here

A biodegradable injectable device for protection of the rectal wall when treating prostate cancer with radiation. BARRIGEL is approved for prostate rectum separation in Australia and Europe.

  • BARRIGEL is CE-Marked and indicated for prostate spacing

  • The prostate spacing market first published with Non-Animal Stabilised Hyaluronic Acid

(NASHA®) in 2007

  • More than 2,500 RT patients have been treated with NASHA

Barrigel is the Next Generation Spacer

NASHA the Proven Solution

  • BARRIGEL is the first commercially available hyaluronic acid (HA) spacer

  • NASHA has a long history of safety, efficacy and biocompatibility

  • Over 40 million treatments with NASHA

NASHA puts you in Control

  • No polymerisation or hardening, allowing unrestricted time for injection quality assurance

  • Gel viscosity remains uniform and consistent to sculpt the space

  • Uniform distribution for desired sculpted space and volume

Moving to BARRIGEL is an easy Transition

BARRIGEL is packaged for immediate use in a single syringe 7

  • 1. No preparation is required (patient ready,

  • single pre-filled syringe)

  • 2. No shaking is required

  • 3. No waiting is required

  • 4. No time constraints

Follow 

  • LinkedIn
  • Twitter
  • YouTube

Call 

0208 205 9500

© 2015 MIS Healthcare, Colindale, London, UK  |  Medical Imaging Systems Limited  |  ICO Registered ZA353845 (Privacy Policy) (Cookie Policy)